Skip to main content
hpa logo
Topics A-Z:
Search the site:

General Information


Chickenpox is an acute, infectious disease caused by the varicella-zoster virus and is most commonly seen in children under 10 years old. This virus, if re-activated in a person who has had chickenpox previously, can also cause shingles (herpes zoster). Shingles tends to be more prevalent in adults.

It is not possible to develop shingles from exposure to a person with chickenpox. It is possible however, to develop chickenpox as a result of exposure to a person with shingles.


Chickenpox is highly contagious, infecting up to 90% of people who come into contact with the disease 1. Transmission is through direct person to person contact, airborne droplet infection or through contact with infected articles such as clothing and bedding. The incubation period (time from becoming infected to when symptoms first appear) is from 10 to 21 days.

The most infectious period is from 1 to 2 days before the rash appears but infectivity continues until all the lesions have crusted over (commonly about 5 to 6 days after onset of illness).

Symptoms of Chickenpox

Chickenpox may initially begin with cold-like symptoms followed by a high temperature and an intensely itchy, vesicular (fluid-filled blister-like) rash. Clusters of vesicular spots appear over 3 to 5 days, mostly over the trunk and more sparsely over the limbs.

The severity of infection varies and it is possible to be infected but show no symptoms.

Shingles (Herpes Zoster)

Following chickenpox infection, the virus can lay dormant in the nervous tissue for several years but may reappear following reactivation of the virus as shingles (also called herpes zoster). It is not known what causes the virus to reactivate but reactivation is usually associated with conditions that depress the immune system such as old age, immunosuppressive therapy and HIV infection 2.

The first sign of herpes zoster is usually pain in the area of the affected nerve - most commonly in the chest. A rash of fluid-filled blisters then appears in the affected area, typically only on one side of the body. This rash is usually present for about 7 days but the pain may persist for longer. Persistent pain is more common in elderly people and is termed 'postherpetic neuralgia'. On average this lasts for 3 to 6 months although it can continue for years.

As mentioned above, people with shingles are contagious to those people who have not had chickenpox. However, it is not possible to catch shingles from a person who has chickenpox.

Possible Complications and High Risk Groups

Chickenpox is usually a mild illness and most healthy children recover with no complications 3.

Certain groups of people however, such as neonates (infants within the first four weeks of life), adults, pregnant women and those who are immunocompromised due to illness or treatments such as chemotherapy or high-dose steroids, may experience more serious complications. These include viral pneumonia, secondary bacterial infections and encephalitis 2.

Varicella infection in pregnant women can cause severe chickenpox with increased risks for the mother from varicella pneumonia and other complications. It also carries the risk of congenital varicella syndrome for the foetus. Congenital varicella syndrome can cause a range of problems including shortened limbs, skin scarring, cataracts and growth retardation 4.

The risk of this occurring within the first 20 weeks of pregnancy has been estimated to be less than 1% in the first 12 weeks and around 2% between 13 and 20 weeks of pregnancy 5.

Occasional cases of fetal damage following maternal varicella infection between 20 to 28 weeks gestation have been reported 6 but the risk is likely to be substantially lower than that of the typical congenital varicella syndrome that can occur in the first 20 weeks gestation.

Infection with varicella in the later stages of pregnancy can cause premature delivery or neonatal chickenpox infection. This is particularly serious if the mother becomes infected 7 days before birth.

For these reasons, pregnant women are offered immunoglobulin - a specially prepared vaccine containing preformed antibodies to help fight the infection.

Guidance on the management of, and exposure to, rash illness in pregnancy.


Chickenpox occurs throughout the year but is most common in winter and spring.

The majority of people are infected in childhood and remain immune for life. However, current epidemiological data shows an increasing trend in the number of first infections affecting older age groups 7. The reason for this is not known but this has important consequences as the infection is more serious in adults and pregnant women.


Chickenpox is not a notifiable disease in England and Wales. Information about the incidence of chickenpox in the UK is available through two sources: cases reported to the Royal College of General Practitioners by sentinel GP practices in England and Wales and in Scotland through statutory notifications.

Since laboratory confirmation of cases of chickenpox is rarely sought as the diagnosis can generally be reliably made on clinical grounds, no laboratory data is available on the Health Protection Agency website.


There is no specific treatment for chickenpox. It is a viral infection that will therefore not respond to antibiotics. Treatment should be based on reducing symptoms such as fever and itchiness.

Shingles can be treated with oral antiviral drugs such as acyclovir.

People at higher risk of developing serious complications from chickenpox or shingles may be given antiviral drugs such as acyclovir and/or immunoglobulin (a specialised preparation of antibodies taken from the plasma of blood donors), which may prevent severe illness developing.


Two live, attenuated varicella vaccines are licensed in the UK (VarilixT - GlaxoSmithKline and Varivax® - Sanofi Pasteur MSD). At present, these are no plans for varicella vaccine to be given routinely to all children but it may be given to children aged 1 to 12 years who are close contacts of those people considered to be at high risk of severe chickenpox or shingles infection. It is also licensed for healthy adults and children over 13 years old who are not immune to varicella (indicated by blood tests).

In December 2003, the Chief Medical Officer announced a new varicella vaccination policy for health care workers. Following advice from the Joint Committee on Vaccination and Immunisation, varicella vaccination is now recommended for non-immune healthcare workers who work in primary care and in hospitals (both NHS and private).

This recommendation covers all non-immune staff who have direct patient contact including ambulance drivers, ward cleaners, catering staff and GP receptionists. Those without a previous history of chickenpox or shingles infection and who are then found to be seronegative to varicella following antibody testing should be offered varicella vaccine.

Full details of this policy can be found in the varicella chapter of Immunisation against Infectious Disease available on the Department of Health website.


  1. Davies EG, Elliman DAC, Hart CA, Nicoll A, Rudd PT . Manual of Childhood Infections 2nd edition Royal College of Paediatrics and Child Health China: WB Saunders, 2001:240-4.
  2. Miller E, Marshall R, Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Reviews in Medical Microbiology 1993; 4:222-30.
  3. Fairly CK, Miller E. Varicella-Zoster Virus Epidemiology - A Changing Scene? The Journal of Infectious Diseases 1996; 174(Suppl 3): S314-9.
  4. Enders G, Miller E. Varicella and herpes zoster in pregnancy and the newborn. Chapter 16 in Arvin A.M., Gershon A.A. (eds) Varicella-zoster virus: virology and clinical management Cambridge : Cambridge University Press 2000: 317-47.
  5. Enders G, Miller E, Cradock-Watson JE, Bolley I, Ridehalgh M. The consequences of chickenpox and herpes zoster in pregnancy; a prospective study of 1739 cases. Lancet 1994: 343:1548-51.
  6. Tan MP and Koren G Chickenpox in pregnancy: Revisited. Reprod Toxicol. 2005 Jun 22; [Epub ahead of print].
  7. Miller E, Vurdien J, Farrington P. Shift in age in chickenpox. Lancet 1993; 341:308-9.